CIPHER
What CIPHER does
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) closes scientific gaps by placing the unique challenges of paediatric and adolescent populations in low- and middle-income countries on the global public health agenda.
Established in 2012, CIPHER accelerates an evidence-informed, human rights-based and integrated HIV response for infants, children, adolescents and young people living with and affected by HIV.
CIPHER in context
A child (aged 0-14 years) dies from AIDS-related causes every six minutes. In 2022, 57% of children living with HIV received antiretroviral therapy compared with 77% of adults, well short of the global target of 95% treatment coverage.
The CIPHER fellowship is incredible. It is a well-rounded programme that is empowering. I have enjoyed the capacity-building opportunities offered by the fellowship and hope to use other opportunities for my career growth in the future.
CIPHER Fellow 2020 – Kopano Dube, South Africa
CIPHER in action
CIPHER builds the next generation of scientists and leaders dedicated to advancing paediatric and adolescent HIV research and programming.
The IAS Collaborative Initiative for Paediatric HIV Education and Research:
-
Addresses major scientific knowledge gaps in paediatric and adolescent HIV research and programming through grants and fellowships, innovative capacity building and collaborative approaches
-
Accelerates the translation of evidence into policies, programmes and care
-
Uses evidence to spotlight critical issues for children, adolescents and young people in the HIV response
Key numbers
Upcoming activities
-
Application for the CIPHER Grant Programme opens on 2 September 2024